Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nantong Stars Synthetic Material Co., Ltd. (also known as Nantong Xingchen) is a major Chinese chemical manufacturer and a key subsidiary of China National BlueStar (Group) Co., Ltd., part of the Sinochem Holdings conglomerate. The company specializes in the production of high-performance engineering plastics and synthetic resins, including polybutylene terephthalate (PBT), polyoxymethylene (POM), and various epoxy resins. Within the healthcare and life sciences sectors, Nantong Stars is a critical supplier of medical-grade polymers used in the fabrication of medical device housings, surgical instruments, and drug delivery systems such as insulin pens and inhalers. Headquartered in Nantong, Jiangsu Province, the company operates large-scale manufacturing facilities and maintains a strong focus on R&D to meet stringent international standards for biocompatibility and chemical resistance. Its products serve as foundational materials for various life science applications, bridging the gap between industrial chemical production and medical technology requirements.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nantong Stars Synthetic Material.